BRIDGET LOLLI: Open Payments
NPI 1710450291 · PAOLI, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$657 in 32 payments from 16 companies in 2025. Trend: 2023 $499 · 2024 $717 · 2025 $657
Food & beverage: $657
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $82 |
| Amgen Inc. | 5 | $76 |
| UCB, Inc. | 4 | $75 |
| Almirall LLC | 2 | $69 |
| Galderma Laboratories, L.P. | 3 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| Organon LLC | 2 | $37 |
| Janssen Biotech, Inc. | 1 | $37 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
Products named: SKYRIZI, Otezla, Bimzelx, DUPIXENT, Klisyri, NEMLUVIO, COSENTYX, TREMFYA.
Industry payments across PA — which companies pay providers there.
